– Fueled by PCF and donor contributions, program has awarded a total of $93 million over nearly three decades to more than 435 researchers – The Prostate Cancer Foundation (PCF) announced that its ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...

– Dr. Hussain was chosen for her extraordinary career in prostate cancer research, profound impact on patients, and mentorship of the next generation of prostate cancer researchers – – Award ...

The Prostate Cancer Foundation (PCF) today announced that Howard R. Soule, Ph.D., will retire as PCF’s Chief Science Officer, ...

BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...

A family history of prostate cancer has long been one of the few universally accepted risk factors for the disease. New findings now provide evidence that risk stratification based on family history ...

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men. The research, published in ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced that its 2024 Young Investigator program has awarded a total of $6.3 million in funding to 30 promising next-generation ...

Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published Aug ...